Skip to main content

Table 1 Statin-eligible groups by 2013 ACC/AHA and NCEP ATP III guidelines

From: Increases in statin eligibility to reduce cardiovascular risk according to the 2013 ACC/AHA cholesterol guidelines in the Africa Middle East region: a sub-analysis of the Africa Middle East Cardiovascular Epidemiological (ACE) study

Statin-eligible group

n (%)

per 2013 ACC/AHA guidelines

 Aged ≥21 y with ASCVD

197 (4.5)

 Aged ≥21 y with untreated LDL-C ≥190 mg/dL

136 (3.1)

 Aged 40–75 y with LDL-C 70–189 mg/dL and DM without ASCVD

510 (11.6)

 Aged 40–75 y with LDL-C 70–189 mg/dL without ASCVD or DM and ASCVD risk ≥7.5%

852 (19.5)

Total eligible

1695 (39.0)

per 2002 NCEP ATP III guidelines

 0–1 risk factor and LDL-C ≥190 mg/dL

104 (2.4)

 ≥ 2 risk factors and LDL-C ≥130 mg/dL

566 (12.9)

 CHD, TIA, stroke, PAD, DM, and LDL-C ≥100 mg/dL

373 (8.5)

Total eligible

1043 (24.0)

  1. ACC/AHA American College of Cardiology/American Heart Association, NCEP ATP III National Cholesterol Education Program Adult Treatment Panel III, ASCVD atherosclerotic cardiovascular disease, LDL-C low-density lipoprotein cholesterol, DM diabetes mellitus, CHD coronary heart disease, TIA transient ischemic attack, PAD peripheral arterial disease